Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

1 year results of patients treated for hyperopic astigmatism by Femto-LASIK

Search Title by author or title

Session Details

Session Title: Surface Photoablation

Session Date/Time: Monday 12/09/2016 | 14:30-16:30

Paper Time: 15:06

Venue: Hall C1

First Author: : K.Kubiak GERMANY

Co Author(s): :    G. Sowwa   I. Pavlovic   M. Remy   M. Shajari   T. Kohnen        

Abstract Details


To evaluate visual outcome and complication rate in eyes with hyperopic astigmatism which have undergone femtosecond laser LASIK treatment.


Department of Ophthalmology, University of Frankfurt, Germany


Between November 2006 and December 2014 82 eyes were treated for hyperopic astigmatism with Femto-LASIK. In 34 eyes of 19 patients preoperative, 1 month postsurgical and 1 year postsurgical data were present and were included in this retrospective study. Preoperative UDVA (logMAR) was 0.5 ±0.25 (0.1 to 1.22) and BDVA was 0.03 ±0.08 (-0.1 to 0.3). Spherical error was + 3.71 D ± 1.22 (+1 to +5D) with astigmatism of – 2.55 D ±1.23 (-0.75D to -5.75D). Visual acuity (logMAR), refraction, complication rate as well as number of retreatments were analyzed.


1 month and 1 year after surgery UDVA was 0.21 ±0.3 (-0.1 to 1.3) and 0.11 ±0.16 (-0.1 to 0.7). 9 eyes had a loss of 1 line of BDVA. Spherical error after 1 month was -0.14D ±0.87 (-4 to +0.75D) with astigmatism of -0.54D ±0.57 (-2 to -0.25D). After 1 year spherical error was 0.2D ±0.82 (-2.25 to +1.75D) with astigmatism of -0.63D ±0.52 (-2 to -0.25D). 4 eyes required retreatment due to residual refractive error, in 1 eye flap was lifted due to severe epithelial ingrowth.


In general treatment of hyperopic astigmatism can be regarded as a safe procedure. However, visual outcome is worse than what is described in the literature for treatment of myopia or hyperopia without an astigmatic component.

Financial Disclosure:


Back to previous